Steven D. Rubin - Jun 15, 2022 Form 4 Insider Report for Eloxx Pharmaceuticals, Inc. (ELOX)

Role
Director
Signature
/s/ Sumit Aggarwal, Attorney-in-Fact for Steven D. Rubin
Stock symbol
ELOX
Transactions as of
Jun 15, 2022
Transactions value $
$0
Form type
4
Date filed
6/17/2022, 08:27 AM
Previous filing
Sep 27, 2021
Next filing
Jun 21, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELOX Stock Options (Right to Buy) Award $0 +20K $0.00 20K Jun 15, 2022 Common Stock 20K $0.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 50% of the underlying shares on June 15, 2023 and the remainder in twelve (12) equal monthly installments thereafter.